Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). I. Design of SCRS and its release controlling factor

Journal of Controlled Release

Volumn 63, Issue 3, 2000, Pages 297-304

  Morita, Ryoichi ^a   Honda, Ritsuko ^a   Takahashi, Yoshiteru ^a  

^a Nippon Organon KK   (Japan)

Author keywords

Controlled release system; Polyvinyl alcohol; PVA swelling controlled release system (SCRS); Swelling; Swelling controlling agent

Indexed keywords

CITRATE TRISODIUM; CITROFLEX; EMEDASTINE; ETHYL CELLULOSE; GELLING AGENT; HYDROXYPROPYLMETHYLCELLULOSE; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ARTICLE; DRUG RELEASE; IN VITRO STUDY; MEMBRANE TRANSPORT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPECTROPHOTOMETRY; SUSTAINED RELEASE PREPARATION;

ADMINISTRATION, ORAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; POLYVINYL ALCOHOL;

EID: 0033991202     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00203-5     Document Type: Article

References (12)

1. Levy G., Jusko W.J. Factors affecting the absorption of riboflavin in man. J. Pharm. Sci. 55:(3):1966;285-289.
2. Jusko W.J., Levy G. Absorption, metabolism, and excretion of riboflavin-5′-phosphate in man. J. Pharm. Sci. 56:(1):1967;58-62.
3. Beermann B., Groschinsky-Grind M. Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food. Eur. J. Clin. Pharmacol. 13:(2):1978;125-128.
4. Suzuki T., Saitoh Y., Isozaki S., Ishida R. Drug absorption and metabolism studies by use of portal vein infusion in the rat. I. Pyloric vein cannulation and its application to study of first-pass effect on bioavailability of propranolol. Chem. Pharm. Bull. 20:1972;2731-2735.
5. Abrams W.B., Coutinho C.B., Leon A.S., Spiegel H.E. Absorption and metabolism of levodopa. J. Am. Med Assoc. 218:1971;1912-1914.
6. Perrier D., Gibaldi M. Influence of first-pass effect on the systemic availability of propoxyphen. J. Clin Pharmacol. 12:1972;449-452.
7. Smolensky M.H., D'Alonzo G.E. Nocturnal asthma mechanisms and chemotherapy. Lemmer B. Chronopharmacorogy - Celluer and Biochemical Interactions. 1989;453-469 Marcel Dekker, New York and Basel.
8. Peters R.W., Zoble R.G., Liebson P.R., et al. Identification of a secondary peak in myocardial infarction onset 11 to 12 h after awakening: the cardiac arrhythmia suppression trial (CAST) experience. J. Am. Coll. Cardiol. 22:1993;998-1003.
9. Portaluppi F., Vergnani L., Manfredini R., et al. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am. J. Hypertens. 8:1995;719-726.
10. Voelkel J. Salt effect during the swelling and dissolution of poly(vinyl alcohol). Influence on the nature of ions. Pol. J. Chem. 55:(2):1981;445-455.
11. Toyoshima K. Chemical property of Poval. Poval. 1970;142-285 Kobunshikankokai, Kyoto.
12. Krzeminski J. The structure of water-swollen poly(vinyl alcohol) and the swelling mechanism. J. Macromol. Sci. Chem. A28:1991;413-429.